How to switch from Wegovy to Zepbound Potential risks and considerations Switching from Wegovy to Zepbound may be associated with these potential risks: You may experience gastrointestinal issues because Zepound has an increased risk of gastrointestinal problems due to its dual mechanism of action Incorrect conversions can cause severe side effects such as hypoglycemia, gallbladder issues, and pancreatitis (inflammation of the pancreas) GLP-1 medications including Zepbound and Wegovy are not recommended during pregnancy, when planning to become pregnant, and when breastfeeding You may experience temporary fluctuations in weight and blood sugar levels Your healthcare insurance company may require a new prior authorization when switching medications or dosages If you experience severe side effects such as allergic reactions or glycemic coma due to incorrect dosage, immediately seek medical attention from a nearby medical facility Tips for a safe and smooth transition Keep a journal or tracking app to mention your medication dosages and any side effects you experience

A: The study found that people on GLP-1s were much less likely to escalate their treatment to more expensive or invasive options, like CGRP antibodies or nerve blocks, suggesting their condition was more stable overall compared to those on standard prevention like topiramate
The primary endpoint was percentage total body weight loss (TBWL%) at the end of the study
Before starting, switching, or stopping any prescription medication, have that conversation with a qualified healthcare provider.
This article provides a comprehensive review that summarizes cellular activities and signalling crosstalk in bone remodelling
These are fundamentally different metabolic pathways with distinct research implications